Patent Assignment
Reel/Frame 021321/0305
Assignment of Assignor's Interest
Recorded: 2008-07-30
Received: 2008-07-30
Pages: 7
Assignee
GRACEWAY PHARMACEUTICALS, LLC
340 MARTIN LUTHER LING JR. BOULEVARD, SUITE 500, BRISTOL, TN, 37620, UNITED STATES
Covered Properties
(26)
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
12/054,357 →
Method and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,887 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,891 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,875 →
Method and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,882 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,870 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,876 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,889 →
Method and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,850 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,890 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,846 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,830 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,892 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,885 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,815 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,881 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,871 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,873 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,811 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,844 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,805 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,817 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,838 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,879 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,835 →
Methods and Packages to Enhance Safety When Using Imiquimod to Treat Children Diagnosed with Skin Disorders
Application:
60/896,792 →